Arrivent Biopharma, Inc. · NASDAQ:AVBP
Sofinnova Venture Partners XI, L.P. ("SVP XI")'s stake in Arrivent Biopharma, Inc. fell to 4.10% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Mar 5, 2026
Sofinnova Venture Partners XI, L.P. ("SVP XI")'s stake in Arrivent Biopharma, Inc. fell to 4.10%, 1,696,752 shares, as a passive investor on Dec 31, 2025. Filed Mar 5, 2026 (Schedule 13G/A).
- Stake
- 4.10%
- Shares
- 1,696,752
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sofinnova Venture Partners XI, L.P. ("SVP XI") | 4.10% | 1,696,752 |
| Sofinnova Management XI, L.P. ("SM XI LP") | 4.10% | 1,696,752 |
| Sofinnova Management XI, L.L.C. ("SM XI LLC") | 4.10% | 1,696,752 |
| Dr. James I. Healy ("Healy") | 4.10% | 1,696,752 |
| Dr. Maha Katabi ("Katabi") | 4.10% | 1,696,752 |
Source
Related
- Arrivent Biopharma, Inc.
- Sofinnova Venture Partners IX, L.P. ("SVP IX")
- Arrivent Biopharma, Inc. shareholders
- Schedule 13G · Vivo Opportunity, LLC · Oct 13, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Oct 8, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Hillhouse Investment Management, Ltd. · Feb 17, 2026